ArticleCancer biology & therapy2015

Cost-effectiveness of RAS screening before monoclonal antibodies therapy in metastatic colorectal cancer based on FIRE3 Study.

Feng Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.